TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
PEPG

PepGen Ltd

Healthcare · Biotechnology

2.40$ -0.4% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns PepGen Ltd (PEPG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 52.2% of the shares are freely tradable; institutional investors hold 90.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 90.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 52.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 8.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 69Mio.

Largest Shareholders

Institutions

Institutions PEPG
Name Stake (%) Shares Change (%) Date
RA Capital Management, LLC 28.97 20,064,545 +0.0 06/30/2026
COMMODORE CAPITAL LP 6.46 4,475,000 +0.0 06/30/2026
Viking Global Investors LP 5.03 3,482,434 +0.0 06/30/2026
LAURION CAPITAL MANAGEMENT LP 3.97 2,750,855 +0.0 06/30/2026
ADAR1 Capital Management LLC 3.74 2,591,085 +61.2 06/30/2026
Vivo Capital, LLC 3.36 2,325,000 +0.0 06/30/2026
Vanguard Capital Management, LLC 2.80 1,935,920 -0.1 06/30/2026
Millennium Management LLC 2.58 1,786,765 -14.1 06/30/2026
Renaissance Technologies Corp 2.20 1,520,246 +2,576.5 06/30/2026

Funds

Funds PEPG
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.03 1,408,449 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?